FDA Approved: ORKAMBI — Original Application (Vertex Pharmaceuticals Incorporated)

View source ↗

Summary

FDA approval of ORKAMBI (lumacaftor and ivacaftor) under an original application by Vertex Pharmaceuticals for cystic fibrosis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cystic Fibrosis

Drugs mentioned

• ORKAMBI (lumacaftor and ivacaftor)

Snippet

ORIG AP for ORKAMBI (LUMACAFTOR AND IVACAFTOR)